Ajanta Pharma Grants 145,000 ESOPs, Cancels 850

Ajanta Pharma's Nomination Committee granted 145,000 employee stock options under its 2019 incentive plan.
The committee also approved the cancellation of 850 stock options, which were returned to the ESOP pool.
This disclosure is made pursuant to Regulation 30 of SEBI LODR Regulations for investor notification.